Dr Sebastian F Koga, MD | |
15752 Medical Arts Plaza Drive, Suite 100, Hammond, LA 70403-1446 | |
(985) 345-7246 | |
(985) 345-7249 |
Full Name | Dr Sebastian F Koga |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 18 Years |
Location | 15752 Medical Arts Plaza Drive, Hammond, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710191184 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD.206783 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Pulse Home Health Care | Covington, LA | Home health agency |
Southern Surgical Hospital | Slidell, LA | Hospital |
North Oaks Medical Center, L L C | Hammond, LA | Hospital |
St Tammany Parish Hospital | Covington, LA | Hospital |
Slidell Memorial Hospital | Slidell, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Koga Llc | 2567890122 | 2 |
News Archive
In Geneva this Friday, a broad range of stakeholders will formally launch the new Strategic Plan 2010-2012 for eradicating wild poliovirus.
The UC Davis Health System's Institute for Population Health Improvement today released the first edition of its "HIE Ready Buyers' Guide" to facilitate health information exchange, especially in California.
"International development agencies may be able to save the lives of a greater number of undernourished children by changing how they allocate food aid in developing countries, suggests a study published [Monday] in Proceedings of the National Academy of Sciences," SciDev.Net reports.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
› Verified 4 days ago
Entity Name | Ochsner Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
In Geneva this Friday, a broad range of stakeholders will formally launch the new Strategic Plan 2010-2012 for eradicating wild poliovirus.
The UC Davis Health System's Institute for Population Health Improvement today released the first edition of its "HIE Ready Buyers' Guide" to facilitate health information exchange, especially in California.
"International development agencies may be able to save the lives of a greater number of undernourished children by changing how they allocate food aid in developing countries, suggests a study published [Monday] in Proceedings of the National Academy of Sciences," SciDev.Net reports.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
› Verified 4 days ago
Entity Name | Koga Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346880010 PECOS PAC ID: 2567890122 Enrollment ID: O20200312001645 |
News Archive
In Geneva this Friday, a broad range of stakeholders will formally launch the new Strategic Plan 2010-2012 for eradicating wild poliovirus.
The UC Davis Health System's Institute for Population Health Improvement today released the first edition of its "HIE Ready Buyers' Guide" to facilitate health information exchange, especially in California.
"International development agencies may be able to save the lives of a greater number of undernourished children by changing how they allocate food aid in developing countries, suggests a study published [Monday] in Proceedings of the National Academy of Sciences," SciDev.Net reports.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sebastian F Koga, MD 42131 Veterans Ave, Suite 100, Hammond, LA 70403-1428 Ph: (985) 345-7246 | Dr Sebastian F Koga, MD 15752 Medical Arts Plaza Drive, Suite 100, Hammond, LA 70403-1446 Ph: (985) 345-7246 |
News Archive
In Geneva this Friday, a broad range of stakeholders will formally launch the new Strategic Plan 2010-2012 for eradicating wild poliovirus.
The UC Davis Health System's Institute for Population Health Improvement today released the first edition of its "HIE Ready Buyers' Guide" to facilitate health information exchange, especially in California.
"International development agencies may be able to save the lives of a greater number of undernourished children by changing how they allocate food aid in developing countries, suggests a study published [Monday] in Proceedings of the National Academy of Sciences," SciDev.Net reports.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
› Verified 4 days ago
Lon F. Alexander, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 15784 Medical Arts Dr Ste B, Hammond, LA 70403 Phone: 985-230-7400 Fax: 985-230-7401 | |
Dr. Aaron Charles Sigler, D.O. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 15770 Paul Vega Md Dr Ste 204, Hammond, LA 70403 Phone: 985-230-7409 | |
Lori E Summers, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Derek Dr Ste 400, Hammond, LA 70403 Phone: 985-419-7767 Fax: 985-419-7771 |